Literature DB >> 32176184

Unique Features of Hospitalized Children with Alveolar Pneumonia Suggest Frequent Viral-Bacterial Coinfections.

Hila Gavrieli1,2, Ron Dagan2, Noga Givon-Lavi1,2, Shalom Ben-Shimol1,2, David Greenberg1,2.   

Abstract

BACKGROUND: The World Health Organization Pneumonia Expert Group (WHO-PEG) defined a standardized radiologic endpoint for childhood community-acquired alveolar pneumonia (RD-CAAP), as the most likely to be pneumococcal, not ruling out other bacteria or coinfecting viruses. We aimed to determine the characteristics associated with hospitalization among children <5 years old presenting to the pediatric emergency room (PER) with RD-CAAP.
METHODS: This study was a part of an ongoing prospective population-based surveillance on hospital visits for RD-CAAP. RD-CAAP was determined according to the WHO-PEG. The study was conducted in the prepneumococcal conjugate vaccine era (2004-2008).
RESULTS: Of 24,432 episodes with chest radiographs, 3871)15.8%) were RD-CAAP: 2319 required hospitalization and 1552 were discharged (outpatients). Compared with outpatients, hospitalized children had lower temperature, peripheral white cell and absolute neutrophil counts and C reactive protein serum levels, but higher rates of hypoxemia, rhinorrhea, cough and respiratory virus detection. PER visits during the respiratory virus season presented a 1.83 times higher risk of hospitalization than visits during nonrespiratory season.
CONCLUSIONS: Although RD-CAAP is most often a bacterial infection, the unique characteristics of those visiting the PER and subsequently hospitalized suggest a frequent involvement of respiratory viruses, potentially as viral-bacterial coinfections, compared with outpatients.

Entities:  

Mesh:

Year:  2020        PMID: 32176184     DOI: 10.1097/INF.0000000000002639

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  3 in total

1.  Effectiveness of Pneumococcal Conjugate Vaccines Against Community-acquired Alveolar Pneumonia Attributable to Vaccine-serotype Streptococcus pneumoniae Among Children.

Authors:  Joseph A Lewnard; Noga Givon-Lavi; Ron Dagan
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 9.079

2.  Assessment of nasopharyngeal Streptococcus pneumoniae colonization does not permit discrimination between Canadian children with viral and bacterial respiratory infection: a matched-cohort cross-sectional study.

Authors:  Jeffrey M Pernica; Kristin Inch; Haifa Alfaraidi; Ania Van Meer; Redjana Carciumaru; Kathy Luinstra; Marek Smieja
Journal:  BMC Infect Dis       Date:  2021-05-31       Impact factor: 3.090

3.  Efficacy of phentolamine combined with ambroxol aerosol inhalation in the treatment of pediatric severe pneumonia and its effect on serum IL-10 and CRP levels.

Authors:  Junxia Li; Haixia Wu; Jingyao Zhang
Journal:  Transl Pediatr       Date:  2022-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.